This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Clinicopathologic Study

Lisa A. Klatka, DO; Randolph B. Schiffer, MD; James M. Powers, MD; Ann Marie Kazee, MD

Arch Neurol. 1996;53(1):35-42.

Abstract
Objectives
To examine the accuracy of clinical diagnoses of Alzheimer's disease (AD) in subjects enrolled in the Rochester Alzheimer's Disease Project (RADP) who were examined at autopsy, and to present a list of clinical "red flags."

Design
Autopsy examination of both prospective and retrospective subjects consecutively enrolled in this clinicopathologic study of the RADP.

Setting
University hospital and research center, using a multidisciplinary geriatric neurology clinic, satellite clinics, nursing home visits, and home visits.

Patients
One hundred seventy subjects clinically diagnosed as having AD who were enrolled in the RADP between 1983 and 1993 underwent neuropathologic examination. Of these, 93 had been enrolled prospectively and 77 retrospectively.

Main Outcome Measures
Agreement between clinical and pathologic diagnoses.

Results
One hundred forty-nine subjects of 170 clinically diagnosed as having AD fulfilled the pathologic criteria for AD, yielding an accuracy rate of 88%. Of 93 subjects enrolled prospectively and diagnosed as having AD, 83 (90%) met the histologic criteria for AD. Of the 77 subjects enrolled retrospectively, neuropathologic examination indicated definite AD in 66 (86%).

Conclusions
There was a high correlation between clinicians' diagnoses and final pathologic diagnoses. The most common clinical errors involved the misdiagnosis of dementias due to Parkinson's disease and cerebrovascular disease. There was no significant difference in the accuracy rates of subjects enrolled prospectively and retrospectively.

Author Affiliations
From the Departments of Neurology (Drs Klatka and Schiffer), Pathology and Laboratory Medicine (Drs Powers and Kazee), and Psychiatry (Dr Schiffer), University of Rochester School of Medicine and Dentistry, Rochester, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical and Psychometric Distinction of Frontotemporal and Alzheimer Dementias
Liscic et al.
Arch Neurol 2007;64:535-540.
ABSTRACT | FULL TEXT  

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha et al.
Arch Neurol 2006;63:674-681.
ABSTRACT | FULL TEXT  

The Diagnostic Value of Cerebrospinal Fluid Tau Protein in Dementing and Nondementing Neuropsychiatric Disorders
Paraskevas et al.
J Geriatr Psychiatry Neurol 2005;18:163-173.
ABSTRACT  

Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Knopman et al.
Mayo Clin Proc. 2003;78:1290-1308.
ABSTRACT  

Biochemical Diagnosis of Alzheimer Disease by Measuring the Cerebrospinal Fluid Ratio of Phosphorylated tau Protein to {beta}-Amyloid Peptide42
Maddalena et al.
Arch Neurol 2003;60:1202-1206.
ABSTRACT | FULL TEXT  

Amyloid precursor protein in platelets: A peripheral marker for the diagnosis of sporadic AD
Padovani et al.
Neurology 2001;57:2243-2248.
ABSTRACT | FULL TEXT  

Prevalence of Alzheimer's disease in very elderly people: A prospective neuropathological study
Polvikoski et al.
Neurology 2001;56:1690-1696.
ABSTRACT | FULL TEXT  

Evaluation of CSF-tau and CSF-A{beta}42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Andreasen et al.
Arch Neurol 2001;58:373-379.
ABSTRACT | FULL TEXT  

Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia
Varma et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:184-188.
ABSTRACT | FULL TEXT  

Diagnostic Criteria for Parkinson Disease
Gelb et al.
Arch Neurol 1999;56:33-39.
ABSTRACT | FULL TEXT  

A Review of Lewy Body Disease, an Emerging Concept of Cortical Dementia
Papka et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:267-279.
ABSTRACT | FULL TEXT  

High Cerebrospinal Fluid Tau and Low Amyloid {beta}42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype
Galasko et al.
Arch Neurol 1998;55:937-945.
ABSTRACT | FULL TEXT  

Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease
Ellis et al.
Arch Neurol 1998;55:360-365.
ABSTRACT | FULL TEXT  

The Validity of the Family History Method for Identifying Alzheimer Disease
Li et al.
Arch Neurol 1997;54:634-640.
ABSTRACT  

Clinicopathological Studies of Alzheimer Disease
Claus
Arch Neurol 1996;53:837-837.
ABSTRACT  

Clinicopathological Studies of Alzheimer Disease-Reply
Klatka
Arch Neurol 1996;53:837-837.
ABSTRACT